Brief of Notice

Health X Platform Limited (formerly known as Sastasundar Ventures Limited) has issued an official regulatory intimation on June 10, 2026, regarding a major decision taken during its recent Board of Directors meeting. The Board has reviewed and approved a comprehensive Composite Scheme of Arrangement and Amalgamation designed to restructure and integrate the group’s operational businesses. This structural reconfiguration involves Health X Platform Limited alongside its group companies: Microsec Resources Private Limited, Innogrow Technologies Limited, and Sastasundar Healthbuddy Limited. The transaction is planned to be structured at arm’s length following standard exchange and entitlement ratios determined by an independent registered valuer, with an appointed execution timeline established from April 01, 2026, subject to relevant standard statutory, regulatory, and judicial approvals.

Details of the Scheme

The approved layout primarily separates the group’s focus into distinct financial and healthcare verticals. Under this framework, the specialized financial services undertaking—handling loan activities, securities management, real estate holdings, and consultancy services—will be demerged directly from Health X Platform Limited into Microsec Resources Private Limited. Regarding equity issuance for this division, shareholders will receive 1 fully paid-up equity share of Microsec Resources Private Limited (Resulting Company) of face value ₹10 for every 3 fully paid-up equity shares they hold in Health X Platform Limited. Concurrently, Innogrow Technologies Limited will fully merge into Microsec Resources Private Limited. In the second leg of the restructuring, the digital pharmacy and supply chain entity, Sastasundar Healthbuddy Limited, will be fully amalgamated back into the parent entity Health X Platform Limited. For this transaction, Health X will issue 85,12,168 equity shares to the minority shareholders of Sastasundar Healthbuddy Limited in exchange for 45,75,830 equity shares held by them, expanding public shareholding in the listed parent entity from 25.93% to 41.57% post-scheme execution.

Business Profile and Corporate Updates

Health X Platform Limited operates a tech-enabled network environment designed to transform the healthcare distribution model within India. The enterprise serves as a foundational bridge connecting consumers, independent local pharmacies, diagnostics services, and medical practitioners. Its consumer-facing operations deploy the digital e-commerce application ‘SastaSundar’ and the business-to-business retail portal ‘Retailer Shakti’ to deliver pharmaceutical logistics and basic diagnostic access efficiently. Moving ahead with its strategic operational map established in 2025, the enterprise officially launched its dedicated generic medicine portfolio brand named ‘JITO’. Management envisions that this newly introduced label will gain steady traction, target a 2% contribution to operational revenue streams in the short term, and scale structurally upwards to command nearly 10% of total revenue within a three-to-four-year timeline.

Financial Growth and Investor Layout

During the financial year 2024–25, Health X Platform Limited navigated mixed market conditions, managing to secure a consolidated full-year operational revenue performance of ₹1,088.5 Crores. The core healthcare vertical acted as the heavy lifting mechanism for the group, generating over 92% of the entity’s incoming top-line receipts. However, intense regional competition, adjustments in operational leverage, and a substantial exceptional loss item of ₹190.6 Crores during 2025 significantly compressed overall profitability, resulting in a net consolidated loss (Profit After Tax) of ₹133.5 Crores for the fiscal stretch. In terms of corporate capital backing, the company has historically drawn notable strategic collaboration and investment depth from the institutional corporate investor Mitsubishi Corporation, which has closely collaborated and parked substantial investments in the group’s subsidiary channels to expand digital logistics and retail footprint scaling.